This inventor holds 3 USPTO granted patents. Top assignee: Millennium Health, LLC. Active years: 2018-2023.
Company Filing History:
Years Active: 2018-2023
Title: The Innovations of Matthew Dedek
Introduction
Matthew Dedek is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of pharmacogenomics, particularly in relation to adverse drug reactions. With a total of three patents to his name, Dedek's work focuses on improving patient safety and treatment outcomes.
Latest Patents
One of Dedek's latest patents is centered around a novel single nucleotide polymorphism (SNP) in HLA-B*15:02. This SNP serves as a biomarker for predicting carbamazepine-induced severe adverse skin reactions, particularly in Asian populations. The patent outlines methods and reagents for assessing this specific SNP, which can help in predicting an increased risk of these severe reactions. This innovation has the potential to significantly enhance personalized medicine approaches in treating patients who require carbamazepine.
Career Highlights
Matthew Dedek is currently employed at Millennium Health, LLC, where he continues to advance his research and innovations. His work is pivotal in the realm of pharmacogenomics, contributing to safer medication practices and better health outcomes for patients.
Collaborations
Dedek collaborates with esteemed colleagues such as Hua Fang and Xiequn Xu. Their combined expertise fosters a productive research environment that drives innovation in the field.
Conclusion
Matthew Dedek's contributions to pharmacogenomics through his patents and collaborations highlight his commitment to improving patient safety. His work exemplifies the importance of innovation in medicine and its potential to transform healthcare practices.